Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
US11926600B2 · kind B2 · utility
0Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2018 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Aug 15, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to sulfonylureas and sulfonylthioureas comprising a monocyclic imidazolyl group of formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.